The effect of monoamine oxidase-B inhibitors on the alleviation of depressive symptoms in Parkinson’s disease: meta-analysis of randomized controlled trials

Non-motor features of Parkinson disease

(2017) Anthony H.V. Schapira et al.   NATURE REVIEWS NEUROSCIENCE

Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson’s Disease

(2017) Carlo Cattaneo et al.   Journal of Parkinsons Disease

Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations

(2017) Anthony H. V. Schapira et al.   JAMA Neurology

The impact of non-motor symptoms on the quality of life of Parkinson's disease patients: a longitudinal study

(2016) K. M. Prakash et al.   EUROPEAN JOURNAL OF NEUROLOGY

Detecting depression in Parkinson disease

(2016) Zahra Goodarzi et al.   NEUROLOGY

The role of serotonergic, adrenergic and dopaminergic receptors in antidepressant-like effect

(2016) Karolina Pytka et al.   Pharmacological Reports

A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients

(2015) P. Barone et al.   EUROPEAN JOURNAL OF NEUROLOGY

Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations

(2013) Rupam Borgohain et al.   MOVEMENT DISORDERS

Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease

(2012) A. H. V. Schapira et al.   EUROPEAN JOURNAL OF NEUROLOGY

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

(2010) Paolo Barone et al.   LANCET NEUROLOGY

Use of antidepressants and the risk of Parkinson's disease: a prospective study

(2009) A Alonso et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

(2009) C. Warren Olanow et al.   NEW ENGLAND JOURNAL OF MEDICINE